Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
ISM-012042 by InSilico Medicine for Inflammatory Bowel Disease: Likelihood of Approval
ISM-012042 is under clinical development by InSilico Medicine and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData,...